Trial Profile
An open label, randomized control study for the comparison of pleiotropic effects between Bolus First and Basal First insulin regimens on patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Apr 2020
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 12 Jul 2012 New trial record